Medical/Pharmaceuticals

InventisBio Announces Positive Phase 2 Study Results for D-2570 (TYK2 Inhibitor) in Patients with Moderate to Severe Plaque Psoriasis

– D-2570 demonstrates robust efficacy and favorable safety profile, achieving skin clearance comparable to leading biologics – SHANGHAI, Dec. 3, 2024 /PRNewswire/ -- InventisBio Co., Ltd. today announced promising results from a Phase 2 clinical trial of D-2570, an oral selective inhibitor of th...

2024-12-03 17:44 1867

AC Health makes critical HIV care more accessible to Filipinos with USAID support

MANILA, Philippines, Dec. 3, 2024 /PRNewswire/ -- Ayala Healthcare Holdings, Inc. (AC Health), in partnership with the U.S. Agency for International Development (USAID), is leading the private sector's efforts to fight the HIV epidemic inthe Philippines by improving access to stigma-free care and...

2024-12-03 16:11 5721

ZEISS Debuts MYO 200 Biometer for Myopia Management in Hong Kong, Built on ZEISS "Gold Standard" Technology to Safeguard the Visual Health of Children and Adolescents

HONG KONG, Dec. 3, 2024 /PRNewswire/ -- Global optical technology leader ZEISS debuted the ZEISS MYO 200 Biometer for Myopia Management inHong Kong on November 28th, to provide more precise myopia control and improved visual health for children and adolescents. Specifically tailored for children ...

2024-12-03 15:13 3126

Pfizer Receives Authorization from Health Authority for Its 20-valent Pneumococcal Conjugate Vaccine for Infants and Children

* In Hong Kong, the 20-valent Pneumococcal Conjugate Vaccine (PCV20) that offers the broadest serotype coverage of any pediatric pneumococcal conjugate vaccine – helping to fight against 20 serotypesleading to most of the invasive pneumococcal diseases and pneumonia[i],[ii] – is now approved fo...

2024-12-03 15:08 2468

HKBU scientist's Automated Multiplex Diagnostics System recommended by WHO as an innovative health technology for low-resource contexts

HONG KONG, Dec. 3, 2024 /PRNewswire/ -- The Automated Multiplex Diagnostics System developed by Professor Terence Lau, Interim Chief Innovation Officer of Hong KongBaptist University (HKBU), has been recommended in the 2024 Compendium of Innovative Health Technologies for Low-resource Settings pu...

2024-12-03 15:03 2051

Beijing Review: Love Without Barriers

BEIJING, Dec. 3, 2024 /PRNewswire/ -- Meide Yanyuan, a courtyard in Beijing's Changping District, is a studio for those seeking prosthetics and orthotics. Here, under the care ofGeorg Hoffmann-Kuhnt, a German prosthetist and orthotist, bodies and lives are given new strength. Many of its visitors...

2024-12-03 14:27 1815

Fosun's Rural Doctors Program Recognized in UNGC's "20 Cases of Private Sector's Sustainable Development in China for 20 Years" Report

HONG KONG, Dec. 3, 2024 /PRNewswire/ -- This year marks the 20th anniversary of the United Nations Global Compact ("UNGC")'s introduction of Environmental, Social, and Governance (ESG) concept and principles. On29 November 2024, the UNGC held a launch event for the "20 Cases of Private Sector's S...

2024-12-03 11:47 2671

Neusoft Medical Systems Showcases AI-powered Medical Imaging Solutions at RSNA 2024

CHICAGO, Dec. 3, 2024 /PRNewswire/ -- Neusoft Medical Systems Co., Ltd. ("Neusoft Medical Systems"), a global leader in medical imaging solutions and services, is proud to announce its participation in the Radiological Society of North America (RSNA) 2024 Annual Meeting, taking place in Chicago fr...

2024-12-03 09:50 3147

ReCerf® Hip Resurfacing Arthroplasty, from MatOrtho® Becomes the World's First All-Ceramic Hip Resurfacing Approved by a Regulatory Authority

Groundbreaking Innovation Receives TGA Approval in Australia LEATHERHEAD, England, Dec. 3, 2024 /PRNewswire/ -- MatOrtho, the UK-based global innovator of hip and knee replacement devices, today announced that the ReCerf® Hip Resurfacing Arthroplasty has become the world's first all-ceramic hip ...

2024-12-03 00:08 2548

2024 Medtec Attracts Over 80,000 Industry Attendees, Helping China's Medical Device Sector Step into a New Era of Quality Development

SHANGHAI, Dec. 2, 2024 /PRNewswire/ -- The 2024 Medtec and the 18th International Medical Device Design & Manufacturing Technology Exhibition (hereinafter referred to as 2024 Medtec), organized by Informa Markets, was successfully held at the Shanghai World Expo Exhibition and Convention Center ...

2024-12-02 23:00 1228

Datasea Hosts Product Promotion Event and Signs Sales Agreement for up to 300,000 High-Tech Acoustic Units

The agreement is expected to generate up to approximately $20.8 million annually BEIJING, Dec. 2, 2024 /PRNewswire/ -- Datasea Inc. (Nasdaq: DTSS) ("Datasea" or the "Company"), aNevada digital technology company focused on innovations in acoustic high-tech and 5G AI multimodal digital technologie...

2024-12-02 22:45 2627

United Imaging Debuts Breakthrough AI-Powered Innovations at RSNA 2024

HOUSTON, Dec. 2, 2024 /PRNewswire/ -- United Imaging, a global leader in manufacturing advanced medical imaging and radiotherapy equipment, will showcase a range of cutting-edge technologies at RSNA 2024. This year's exhibit will include several new product debuts in the fields of magnetic resona...

2024-12-02 22:00 1960

ACROBiosystems' US Innovation Lab Earns ISO 17025 Accreditation to Accelerate Biomedicine Discovery and Development

NEWARK, Del., Dec. 2, 2024 /PRNewswire/ -- ACROBiosystems' US Innovation Lab has recently achieved ISO/IEC 17025 accreditation for its Surface Plasmon Resonance (SPR) analytical service, ensuring that results from this service is globally recognized and trusted for its precision and consistency. ...

2024-12-02 22:00 2048

MeditWave 2024 in Porto Brings Together Global Experts to Shape the Future of Digital Dental Solutions

PORTO, Portugal, Dec. 2, 2024 /PRNewswire/ -- On November 9, Medit, a global leader in digital dentistry solutions, hosted its two-day MeditWave 2024 in Porto, Portugal. This dynamic gathering of dental professionals from around the world fostered valuable exchanges and showcased the latest innova...

2024-12-02 22:00 1933

Real-World Validation: Lunit AI Proven Successful in 1-Year Breast Cancer Screening Deployment

Follow-up to ScreenTrustCAD presented at RSNA 2024 highlights 1-year post-AI adoption success in improving cancer detection, radiologist workload, and screening efficiency SEOUL, South Korea, Dec. 2, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cance...

2024-12-02 22:00 2339

Health On Cloud Showcases Innovative Healthcare Solutions at the Korea-LAC Trade and Innovation Forum, Accelerating Expansion into Latin America

SEOUL, South Korea, Dec. 2, 2024 /PRNewswire/ -- Health On Cloud (HOC) is impactingColombia's healthcare sector through the use of digital innovations in a pilot project funded by the Inter-American Development Bank (IDB). This initiative is scheduled to expand toMexico and Brazil in the first ha...

2024-12-02 22:00 2148

European Wellness Biomedical Group, Headed by Prof. Mike Chan, Releases New Study on Bioregenerative Blueprint for Athletic Longevity

KOTA KINABALU, Malaysia, Dec. 2, 2024 /PRNewswire/ -- European Wellness Biomedical Group (EWBG), a global leader in regenerative medicine, has unveiled a groundbreaking study led by renowned expert Prof.Mike Chan on the physiological challenges aging athletes face. The analysis explores how age ...

2024-12-02 16:30 3762

Fangzhou Inc. Strengthens Partnerships with Tencent and Baidu, Unveiling its "AI Agent Solution"

CHENGDU, China, Dec. 2, 2024 /PRNewswire/ -- On November 22, 2024, Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, hosted the "Data and AI: Decoding Digital Engagement" summit in Chengdu, bringing together key representatives from leading Internet...

2024-12-02 15:21 2289

MGI Tech announces partnership with Universidad de San Martín de Porres to strengthen human genetics research

* The implementation of MGI Tech's next-generation genomic sequencing (NGS) technologies will strengthen scientific research in the country, enabling the identification of key genetic variations, contributing to disease prevention, and personalizing medical treatments. * A team of specialists...

2024-12-02 11:16 1795

Everest Medicines Announces Acceptance of VELSIPITY® New Drug Application in Hong Kong

SHANGHAI, Dec. 2, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that Department of Health of the Gover...

2024-12-02 07:40 2660
1 ... 145146147148149150151 ... 646

Week's Top Stories